首页> 外文期刊>Journal of materials science >A covalently crosslinked polysaccharide hydrogel for potential applications in drug delivery and tissue engineering
【24h】

A covalently crosslinked polysaccharide hydrogel for potential applications in drug delivery and tissue engineering

机译:共价交联的多糖水凝胶,在药物输送和组织工程中的潜在应用

获取原文
获取原文并翻译 | 示例
           

摘要

The development of non-cytotoxic hydrogels that can allow for the controlled release of molecules has important clinical and therapeutic applications. In this paper, we developed a series of in situ hydrogels by combining N,O-carboxymethyl chitosan and oxidized alginate without additional crosslinking agents. The rheo-logical properties of these hydrogels as well as their gelling time, swelling ratio, and in vitro degradation behavior were investigated. We observed that although gelation was rapid at physiological temperature, it was even faster in the presence of higher oxidization degree of alginate. In vitro cytotoxicity study showed that the developed hydrogels were not cytotoxic after 24 h of culturing with NIH-3T3 cells. Additionally, bovine serum albumin was released from the hydrogels initially by diffusion at early stages followed by a degradation-dependent mechanism at later stages. In conclusion, the developed hydrogel might have potential application in the drug delivery system and tissue engineering.
机译:可以控制分子释放的非细胞毒性水凝胶的开发具有重要的临床和治疗应用。在本文中,我们通过将N,O-羧甲基壳聚糖和氧化藻酸盐混合而无需其他交联剂,开发了一系列原位水凝胶。研究了这些水凝胶的流变性,胶凝时间,溶胀率和体外降解行为。我们观察到,尽管在生理温度下胶凝作用很快,但是在藻酸盐氧化度较高的情况下,胶凝作用甚至更快。体外细胞毒性研究表明,与NIH-3T3细胞培养24小时后,已开发的水凝胶无细胞毒性。另外,牛血清白蛋白最初是通过早期扩散从水凝胶中释放出来的,随后在后期扩散依赖于机理的。总之,开发的水凝胶可能在药物递送系统和组织工程中具有潜在的应用。

著录项

  • 来源
    《Journal of materials science》 |2012年第12期|2857-2865|共9页
  • 作者单位

    Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical College, 270 Xueyuan Road, Wenzhou 325027, China;

    Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical College, 270 Xueyuan Road, Wenzhou 325027, China;

    State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, No. 1, Keyuan 4th Road, Chengdu 610041, China;

    Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical College, 270 Xueyuan Road, Wenzhou 325027, China;

    Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical College, 270 Xueyuan Road, Wenzhou 325027, China;

    Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical College, 270 Xueyuan Road, Wenzhou 325027, China;

    Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical College, 270 Xueyuan Road, Wenzhou 325027, China;

    Department of Lymphoma, Sino-US Center for Lymphoma and Leukemia, Tianjin Medical University Cancer Hospital and Institute, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Tianjin 300060, China;

    Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical College, 270 Xueyuan Road, Wenzhou 325027, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号